M2 Macrophage-Derived Exosomes Promote Tendon-to-Bone Healing by Alleviating Cellular Senescence in Aged Rats

Zhuochang Cai1, Longqiang Shu1, Chongyang Wang1

  • 1Department of Orthopedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Abstract

Insights

M2 macrophage-derived exosomes (M2-Exos) reduce cellular senescence in bone marrow-derived stem cells (BMSCs), significantly improving tendon-to-bone healing in aged rats with rotator cuff tears.

Area of Science:

  • Regenerative Medicine
  • Biomaterials Science
  • Aging Research

Background:

  • Cellular senescence in bone marrow-derived stem cells (BMSCs) impairs tendon-to-bone healing, particularly in aged individuals.
  • Rotator cuff tears (RCTs) in older populations have poor healing outcomes due to age-related cellular dysfunction.

Purpose of the Study:

  • To investigate the therapeutic potential of M2 macrophage-derived exosomes (M2-Exos) for enhancing tendon-to-bone healing in aged rats.
  • To determine if M2-Exos can mitigate cellular senescence in BMSCs and improve their regenerative capacity.

Main Methods:

  • In vitro assessment of M2-Exos' effects on senescent BMSCs' senescence markers and chondrogenic potential.
  • Evaluation of enthesis regeneration in young and aged rats with RCTs treated with fibrin or fibrin plus M2-Exos at 6 and 12 weeks.
  • Proteomic analysis to elucidate the mechanism of M2-Exos in alleviating BMSC senescence.

Main Results:

  • M2-Exos significantly reduced senescence biomarkers (e.g., p53, p21) and enhanced chondrogenic potential in senescent BMSCs.
  • Aged rats treated with M2-Exos showed improved histological scores and fibrocartilage regeneration at the enthesis.
  • M2-Exos treatment led to superior biomechanical properties (failure load, stiffness, stress) at 12 weeks post-repair in aged rats.

Conclusions:

  • M2-Exos effectively alleviate BMSC senescence, thereby promoting tendon-to-bone healing in an aged rat RCT model.
  • M2-Exos represent a promising therapeutic strategy for rotator cuff repair in the elderly population.